SCHEMBL29230960

SCHEMBL29230960

CC(C)c1ccc(C(NC(=O)C2CC(F)CN2C(=O)Cc2ncco2)c2ccccc2)nc1F

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ PSMB9 P28065 1/20 0.34
▸ CFD P00746 16/20 0.34
▸ ITGA4 P13612 2/20 0.34
▸ XIAP P98170 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24664507 1.00 PSMB9 (0.34) PSMB9CFDITGA4XIAP
SCHEMBL24666074 0.89 CFD (0.36) PSMB9CFDITGA4XIAP
SCHEMBL29231075 0.89 CFD (0.36) PSMB9CFDITGA4XIAP
SCHEMBL29820391 0.88 CFD (0.35) PSMB9CFD
SCHEMBL24666370 0.88 CFD (0.35) PSMB9CFD
SCHEMBL29231143 0.88 CFD (0.36) PSMB9CFDITGA4
SCHEMBL24666073 0.88 CFD (0.36) PSMB9CFDITGA4
SCHEMBL30341454 0.88 CFD (0.35) PSMB9CFD
SCHEMBL29230957 0.88 CFD (0.35) PSMB9CFD
SCHEMBL24665707 0.88 CFD (0.32) CFD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117956985-A Inhibitors of glycogen synthase 1 (GYS 1) and methods of use thereof 梅兹治疗公司 2024-04-30 — — CN disclosed
EP-4308095-A1 INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF Maze Therapeutics, Inc. (US) 2024-01-24 — — EP disclosed
WO-2022198196-A1 INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2022-09-22 — — WO disclosed
Send feedback